(5-157) An Assessment of COVID-19 Clinical Trial Design Demographics and Outcome Measures Associated with Hydroxychloroquine and Ivermectin

Monday, December 5, 2022

4:15 PM – 5:15 PM

Location: Bayside A, Level 1

Category: Evaluative Study
Topic: Drug Information/Drug Use Evaluation

Co-Author(s): Srayant Gayam, Kristina Royzman, Michael Toscani, Paul Weber

Primary Author(s)

Anuj R. Bambhrolia
PharmD Candidate 2023
Rutgers University Ernest Mario School of Pharmacy, New Jersey